Evidence map›Paper›PMID 40216967›Full record

ArticleOncogene2025

Protein disulfide isomerase-enriched extracellular vesicles from bladder cancer cells support tumor survival and malignant transformation in the bladder.

Chia-Hao Wu, Kit L Yuen, Ryan D Molony, Christopher R Silvers, Md Mahmudul Hasan Akash, Edward M Messing, Yi-Fen Lee

Abstract read
In one paragraph

Article in Oncogene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chia-Hao WuDepartment of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY14642, USA.
Kit L YuenDepartment of Urology, University of Rochester Medical Center, Rochester, NY14642, USA.
Ryan D MolonyDepartment of Urology, University of Rochester Medical Center, Rochester, NY14642, USA.
Christopher R SilversDepartment of Urology, University of Rochester Medical Center, Rochester, NY14642, USA.
Md Mahmudul Hasan AkashDepartment of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY14642, USA.
Edward M MessingDepartment of Urology, University of Rochester Medical Center, Rochester, NY14642, USA.
Yi-Fen LeeDepartment of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, NY14642, USA. YiFen_Lee@URMC.Rochester.edu.ORCID http://orcid.org/0000-0002-7766-6738

Funding

University of Rochester Wilmot Cancer Institute Support GrantP30CA272302 · NCI · UNIVERSITY OF ROCHESTER · PI JONATHAN W FRIEDBERG · 2025 to 2026
$6.4M
NCI NIH HHS P30 CA272302
6 · The paper itself

Abstract

Bladder cancer (BC) patients face high rates of disease recurrence, partially driven by the cancer field effect. This effect is mediated in part by the release of pro-tumorigenic cargos in membrane-enclosed extracellular vesicles (EVs), but the specific underlying mechanisms remain poorly understood. Protein disulfide isomerase (PDIA1) catalyze disulfide bond formation and can help mitigate endoplasmic reticulum (ER) stress, potentially supporting tumor survival. Here, BC cells were found to exhibit better survival under ER stress when PDIA1 was downregulated. These cells maintained homeostatic PDIA1 levels through the EV-mediated release of PDIA1. Chronic exposure of urothelial cells to these PDIA1-enriched BCEVs induced oxidative stress and DNA damage, ultimately leading to the malignant transformation of recipient cells. The EV-transformed cells exhibited DNA damage patterns potentially attributable to oxidative damage, and PDIA1 was found to be a key tumorigenic cargo within EVs. Tissue microarray analyses of BC recurrence confirmed a significant correlation between tumor recurrence and the levels of both PDIA1 and ER stress. Together, these data suggest that cancer cells selectively sort oxidized PDIA1 into EVs for removal, and these EVs can, in turn, induce oxidative stress in recipient urothelial cells, predisposing them to malignant transformation and thereby increasing the risk of recurrence.

Indexed as

Cell Transformation, NeoplasticExtracellular VesiclesProcollagen-Proline DioxygenaseProtein Disulfide-IsomerasesUrinary Bladder NeoplasmsAnimalsCell Line, TumorCell SurvivalDNA DamageEndoplasmic Reticulum StressHumansNeoplasm Recurrence, LocalOxidative StressUrinary BladderProcollagen-Proline DioxygenaseProtein Disulfide-Isomerases

Identifiers

PMID40216967
PMCPMC12183083

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.